Parnell Pharmaceuticals Holdings Ltd
Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproduc… Read more
Market Cap & Net Worth: Parnell Pharmaceuticals Holdings Ltd (PARNF)
Parnell Pharmaceuticals Holdings Ltd (PINK:PARNF) has a market capitalization of $1.68 Million ($1.68 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #48474 globally and #14894 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Parnell Pharmaceuticals Holdings Ltd's stock price $0.08 by its total outstanding shares 21048700 (21.05 Million).
Parnell Pharmaceuticals Holdings Ltd Market Cap History: 2015 to 2025
Parnell Pharmaceuticals Holdings Ltd's market capitalization history from 2015 to 2025. Data shows change from $81.67 Million to $1.68 Million (-32.66% CAGR).
Parnell Pharmaceuticals Holdings Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Parnell Pharmaceuticals Holdings Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Parnell Pharmaceuticals Holdings Ltd's market cap is 0.00 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $81.67 Million | $19.89 Million | -$13.74 Million | 4.11x | N/A |
| 2016 | $14.53 Million | $19.97 Million | -$21.69 Million | 0.73x | N/A |
| 2017 | $12.63 Million | $19.13 Million | -$23.13 Million | 0.66x | N/A |
| 2018 | $3.33 Million | $26.55 Million | $129.62K | 0.13x | 25.66x |
| 2019 | $2.42 Million | $28.99 Million | -$7.18 Million | 0.08x | N/A |
| 2020 | $7.41 Million | $30.00 Million | -$15.06 Million | 0.25x | N/A |
| 2021 | $2.10K | $34.17 Million | -$1.42 Million | 0.00x | N/A |
Competitor Companies of PARNF by Market Capitalization
Companies near Parnell Pharmaceuticals Holdings Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Parnell Pharmaceuticals Holdings Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Parnell Pharmaceuticals Holdings Ltd Historical Marketcap From 2015 to 2025
Between 2015 and today, Parnell Pharmaceuticals Holdings Ltd's market cap moved from $81.67 Million to $ 1.68 Million, with a yearly change of -32.66%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.68 Million | +79900.00% |
| 2024 | $2.10K | 0.00% |
| 2023 | $2.10K | -96.00% |
| 2022 | $52.62K | +2400.00% |
| 2021 | $2.10K | -99.97% |
| 2020 | $7.41 Million | +206.09% |
| 2019 | $2.42 Million | -27.22% |
| 2018 | $3.33 Million | -73.67% |
| 2017 | $12.63 Million | -13.06% |
| 2016 | $14.53 Million | -82.21% |
| 2015 | $81.67 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Parnell Pharmaceuticals Holdings Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.68 Million USD |
| MoneyControl | $1.68 Million USD |
| MarketWatch | $1.68 Million USD |
| marketcap.company | $1.68 Million USD |
| Reuters | $1.68 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.